Equities

Zhejiang Qianjiang Biochemical Co Ltd

600796:SHH

Zhejiang Qianjiang Biochemical Co Ltd

Actions
Basic MaterialsChemicals
  • Price (CNY)4.03
  • Today's Change-0.08 / -1.95%
  • Shares traded1.64m
  • 1 Year change-26.33%
  • Beta0.5349
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

SmartText is unavailable
Gross margin22.80%
Net profit margin8.52%
Operating margin10.76%
Return on assets2.46%
Return on equity6.72%
Return on investment3.45%
More ▼

Cash flow in CNYView more

In 2023, Zhejiang Qianjiang Biochemical Co Ltd did not generate a significant amount of cash. However, the company earned 352.03m from its operations for a Cash Flow Margin of 17.30%. In addition the company used 143.14m on investing activities and also paid 209.52m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share3.69
Tangible book value per share0.1948
More ▼

Balance sheet in CNYView more

Zhejiang Qianjiang Biochemical Co Ltd has a Debt to Total Capital ratio of 42.03%, a higher figure than the previous year's 39.16%.
Current ratio1.38
Quick ratio1.27
Total debt/total equity0.8029
Total debt/total capital0.4203
More ▼

Growth rates in CNY

Year on year, growth in dividends per share fell -69.61% while earnings per share excluding extraordinary items rose 2.25%.
Div yield(5 year avg)0.84%
Div growth rate (5 year)--
Payout ratio (TTM)12.89%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-1.41
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.